|
Published by: Datamonitor
Published: Aug. 23, 2001 - 77 Pages
Table of Contents
DATAMONITOR HEALTHCARE
CONTACT DETAILS
EXECUTIVE SUMMARY
Scope
Datamonitor insight into the OCD market
Key metrics
TABLE OF CONTENTS
EPIDEMIOLOGY
OCD overview
Definition
Symptoms
Etiology
Comorbidities
Major depression
Anxiety disorders
Tourette's syndrome
Schizophrenia
Patient population
Prevalence
Epidemiological conclusion
CLINICAL PRACTICE
Introduction
Diagnosis
Guidelines in exsistence
Physician diagnosis rate
Treatment
Breakdown of OCD in anxiety disorders
First line OCD treatment
Overall OCD treatment
Influence on OCD marketing
The strength of efficacy data
The need to treat comorbid disorders
The potential for product bundling
CURRENT OCD MARKET
Antidepressant use in OCD
The indicated players
Luvox
Prozac
Zoloft
Paxil
Comparison of leading products
Other antidepressant players
Celexa/Cipramil
Serzone
Clomipramine
St John's Wort
Antipsychotic drugs used to treat OCD
Risperdal
Zyprexa
Treatment conclusions
The global OCD market 2001
THE FUTURE DECODED
Unmet needs in treating OCD
The OCD R&D pipeline
Fluoxetine
Fluvoxamine
Fluvoxamine CR
The OCD market 2001-2008
Factors influencing the future OCD market
Future drug launches
OCD market forecast to 2008
OCD market forecast 2005
OCD market forecast 2008
APPENDIX
Datamonitor's Central Nervous System Business Unit
Table of tables
Bibliography
Epidemiology
Clinical trials
Websites
R&D research methodology
Introduction
Hypothesis formulation
Hypothesis testing
Data verification and quality control
Physician research questionnaire
Diagnosis
Treatment
Unmet needs
Pricing data
Introduction
Source prices
Ex-manufacturer, wholesaler and retail prices
Data validation and margin calculation
Quality control
Patent expiries
AbstractDatamonitor's Strategic Perspectives 2001: Anxiety Disorders series of eight reports form a comprehensive review of major anxiety and eating disorder markets. Each report utilizes primary research data in the seven leading healthcare markets and investigates the current state of affairs in each market. Furthermore they provide an in-depth analysis of the current pipeline, estimated drug launches and the future direction of each anxiety disorder. Anxiety Disorders covered: Eating Disorders (Anorexia Nervosa and Bulimia Nervosa)Generalized Anxiety Disorder Obsessive Compulsive DisorderPanic Disorder Phobias (Specific Phobia and Agoraphobia)Post Traumatic Stress Disorder Premenstrual Dysphoric Disorder Social Anxiety Disorder
Get Full Details About This Report >>
|
